Tags

Type your tag names separated by a space and hit enter

[Therapy of arterial-circulation disorders in the legs. Muscle-ergometric studies under the effects of butalamine hydrochloride in a double-blind trial].
Fortschr Med. 1976 Apr 22; 94(12):725-7.FM

Abstract

The extent to which a 10-day-treatment with Butalamine hydrochloride (3 X 2 tablets daily) may increase the muscular capacity in patients suffering from blood flow disorders of the lower limb was studied in a cross-over double-blind-trial. According to Fontaine comparative tests were performed with placebo and the substance in 19 patients suffering from stage II occlusion (either unilateral or bilateral). The muscular capacity in legs with blood flow disorders was found to be significantly improved by the drug compared to the placebo. Except in the case of exercise effect, the muscular capacity of the "intact" extremity however was not found to be significantly improved by the drug. Further specific studies with show whether the walking distance is improved by an increase in muscular capacity.

Authors

No affiliation info available

Pub Type(s)

Clinical Trial
Controlled Clinical Trial
English Abstract
Journal Article
Randomized Controlled Trial

Language

ger

PubMed ID

823084

Citation

Bopp, J. "[Therapy of Arterial-circulation Disorders in the Legs. Muscle-ergometric Studies Under the Effects of Butalamine Hydrochloride in a Double-blind Trial]." Fortschritte Der Medizin, vol. 94, no. 12, 1976, pp. 725-7.
Bopp J. [Therapy of arterial-circulation disorders in the legs. Muscle-ergometric studies under the effects of butalamine hydrochloride in a double-blind trial]. Fortschr Med. 1976;94(12):725-7.
Bopp, J. (1976). [Therapy of arterial-circulation disorders in the legs. Muscle-ergometric studies under the effects of butalamine hydrochloride in a double-blind trial]. Fortschritte Der Medizin, 94(12), 725-7.
Bopp J. [Therapy of Arterial-circulation Disorders in the Legs. Muscle-ergometric Studies Under the Effects of Butalamine Hydrochloride in a Double-blind Trial]. Fortschr Med. 1976 Apr 22;94(12):725-7. PubMed PMID: 823084.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Therapy of arterial-circulation disorders in the legs. Muscle-ergometric studies under the effects of butalamine hydrochloride in a double-blind trial]. A1 - Bopp,J, PY - 1976/4/22/pubmed PY - 1976/4/22/medline PY - 1976/4/22/entrez SP - 725 EP - 7 JF - Fortschritte der Medizin JO - Fortschr. Med. VL - 94 IS - 12 N2 - The extent to which a 10-day-treatment with Butalamine hydrochloride (3 X 2 tablets daily) may increase the muscular capacity in patients suffering from blood flow disorders of the lower limb was studied in a cross-over double-blind-trial. According to Fontaine comparative tests were performed with placebo and the substance in 19 patients suffering from stage II occlusion (either unilateral or bilateral). The muscular capacity in legs with blood flow disorders was found to be significantly improved by the drug compared to the placebo. Except in the case of exercise effect, the muscular capacity of the "intact" extremity however was not found to be significantly improved by the drug. Further specific studies with show whether the walking distance is improved by an increase in muscular capacity. SN - 0015-8178 UR - https://www.unboundmedicine.com/medline/citation/823084/[Therapy_of_arterial_circulation_disorders_in_the_legs__Muscle_ergometric_studies_under_the_effects_of_butalamine_hydrochloride_in_a_double_blind_trial]_ DB - PRIME DP - Unbound Medicine ER -